V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167748 | 20063979 | 1.59 | 108.7 | Neo-adjuvant (N) | 2018-06-04 | 2018-06-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100243101 |
| 20167753 | 20063980 | 1.76 | 84.3 | Palliative (P) | 2019-11-18 | 2019-12-26 | ECX | 02 | N | FLUOROURACIL | 100038467 |
| 20167766 | 20063981 | 1.62 | 59.5 | Curative (C) | 2017-07-19 | 2017-08-12 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100776393 |
| 20167769 | 20063982 | 1.66 | 49.3 | Adjuvant (A) | 2018-05-31 | 2018-07-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101279948 |
| 20167777 | 20063983 | 1.51 | 63.3 | Palliative (P) | 2018-05-19 | 2018-05-19 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101794183 |
| 20167785 | 20063984 | 1.56 | 77.8 | Adjuvant (A) | 2019-03-21 | 2019-04-04 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100819125 |
| 20167794 | 20063985 | 1.72 | 88.1 | Neo-adjuvant (N) | 2016-05-26 | 2016-05-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100716842 |
| 20167798 | 20063986 | 1.64 | 60.1 | Neo-adjuvant (N) | 2018-08-15 | 2018-08-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100911948 |
| 20167799 | 20063987 | 1.65 | 78 | Neo-adjuvant (N) | 2018-04-30 | 2018-05-13 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101403716 |
| 20167805 | 20063988 | 1.66 | 106.7 | Curative (C) | 2018-01-02 | 2018-02-05 | Fluorouracil + Folinic Acid Weekly | 2 | N | FLUOROURACIL | 100442503 |
| 20167806 | 20063989 | 1.7 | 88.4 | Palliative (P) | 2018-06-08 | 2018-06-23 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100880219 |
| 20167807 | 20063990 | 1.74 | 79.1 | Curative (C) | 2017-11-14 | 2017-11-20 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101140763 |
| 20167809 | 20063991 | 1.63 | 122 | Palliative (P) | 2019-05-18 | 2019-05-29 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100780302 |
| 20167822 | 20063992 | 1.57 | 50 | Curative (C) | 2017-03-10 | 2017-03-30 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101365244 |
| 20167827 | 20063993 | 1.53 | 118 | Curative (C) | 2016-08-08 | 2016-08-09 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101711366 |
| 20167831 | 20063994 | 1.57 | 110 | Palliative (P) | 2018-03-27 | 2018-04-01 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100746938 |
| 20167834 | 20063995 | 1.74 | 90 | Curative (C) | 2015-10-19 | 2015-11-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100211759 |
| 20167846 | 20063996 | 1.77 | 64 | Curative (C) | 2019-01-23 | 2019-02-09 | FLUOROURACIL + RT | 02 | N | FLUOROURACIL | 100333403 |
| 20167850 | 20063997 | 1.69 | 71.3 | Palliative (P) | 2017-02-03 | 2017-02-12 | Fluorouracil + Folinic Acid Weekly | null | N | FLUOROURACIL | 101539477 |
| 20167855 | 20063998 | 1.83 | 79.4 | Neo-adjuvant (N) | 2019-06-15 | 2019-06-20 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100557582 |
| 20167857 | 20063999 | 1.8 | 79.9 | Neo-adjuvant (N) | 2016-07-20 | 2016-08-08 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100781907 |
| 20167858 | 20064000 | 1.5 | 55.5 | Neo-adjuvant (N) | 2017-11-19 | 2017-12-03 | ECX | 02 | N | FLUOROURACIL | 101087306 |
| 20167868 | 20064001 | 1.55 | 96 | Palliative (P) | 2018-12-31 | 2019-01-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100835586 |
| 20167869 | 20064002 | 1.52 | 56.4 | Neo-adjuvant (N) | 2016-07-17 | 2016-07-18 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100514339 |
| 20167870 | 20064003 | 1.86 | null | Curative (C) | 2017-12-10 | 2018-01-10 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 100163644 |
| 20167871 | 20064004 | 1.6 | 66.7 | Neo-adjuvant (N) | 2017-07-14 | 2017-08-05 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100419013 |
| 20167876 | 20064005 | 1.77 | 64.9 | Adjuvant (A) | 2016-11-27 | 2016-12-05 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101741853 |
| 20167878 | 20064006 | 1.7 | 78.4 | Neo-adjuvant (N) | 2018-05-06 | 2018-05-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100277899 |
| 20167879 | 20064007 | 1.61 | 66.3 | Curative (C) | 2017-01-28 | 2017-02-20 | FLUOROURACIL | N | N | FLUOROURACIL | 100001280 |
| 20167890 | 20064008 | 1.87 | 75.8 | Palliative (P) | 2017-10-22 | 2017-10-27 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100504689 |
| 20167891 | 20064009 | 1.64 | 89.7 | null | 2019-08-09 | 2019-08-18 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101639682 |
| 20167895 | 20064010 | 1.56 | 88.4 | null | 2019-06-06 | 2019-06-21 | Fluorouracil + Folinic Acid Weekly | 2 | null | FLUOROURACIL | 101083033 |
| 20167905 | 20064011 | 1.74 | 70 | Curative (C) | 2016-11-13 | 2016-11-19 | Fluorouracil + Folinic Acid Weekly | 02 | null | FLUOROURACIL | 100952335 |
| 20167911 | 20064012 | null | null | Adjuvant (A) | 2017-07-11 | 2017-07-19 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101175007 |
| 20167912 | 20064013 | 1.8 | 93.8 | Neo-adjuvant (N) | 2018-10-12 | 2018-10-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100378309 |
| 20167913 | 20064014 | 1.84 | 84.4 | Neo-adjuvant (N) | 2016-11-24 | 2016-12-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100232606 |
| 20167915 | 20064015 | 1.84 | 54 | Curative (C) | 2018-11-23 | 2018-12-01 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100653619 |
| 20167921 | 20064016 | 1.6 | 56.2 | Adjuvant (A) | 2019-05-01 | 2019-05-02 | FLUOROURACIL | 02 | null | FLUOROURACIL | 101792043 |
| 20167924 | 20064017 | 1.75 | 133 | Palliative (P) | 2019-12-22 | 2020-01-17 | FLUOROURACIL | 02 | Y | FLUOROURACIL | 101461322 |
| 20167928 | 20064018 | 1.55 | 123 | Adjuvant (A) | 2017-11-18 | 2017-12-10 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100085759 |
| 20167935 | 20064019 | 1.77 | 84.2 | Neo-adjuvant (N) | 2017-12-13 | 2017-12-31 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100979453 |
| 20167937 | 20064020 | 1.74 | 74 | Palliative (P) | 2008-03-05 | 2016-11-23 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101121916 |
| 20167941 | 20064021 | 1.83 | 59.7 | Neo-adjuvant (N) | 2017-08-31 | 2017-09-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101135812 |
| 20167954 | 20064022 | null | null | Neo-adjuvant (N) | 2016-03-06 | 2016-03-08 | Fluorouracil + Folinic Acid Weekly | null | N | FLUOROURACIL | 101642183 |
| 20167957 | 20064023 | null | null | Neo-adjuvant (N) | null | null | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100387103 |
| 20167965 | 20064024 | 1.82 | 75.6 | null | 2017-05-28 | 2017-05-28 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101543194 |
| 20167967 | 20064025 | 1.77 | 99.1 | Palliative (P) | 2019-10-09 | 2019-10-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100555958 |
| 20167970 | 20064026 | 1.63 | 52 | Adjuvant (A) | 2017-02-27 | 2017-02-27 | FLUOROURACIL | 2 | N | FLUOROURACIL | 100001789 |
| 20167974 | 20064027 | 1.59 | 89.6 | Adjuvant (A) | 2019-10-07 | 2019-10-22 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 100601700 |
| 20167975 | 20064028 | 1.77 | 69 | Neo-adjuvant (N) | 2017-01-07 | 2017-01-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101047398 |